tirzepatide update Breaking News: OFA Challenges FDA on Shortage Ruling back pain with tirzepatide Unanticipated

August 1, 2025: People Who Lost Their Vision on Rybelsus May Be Able to Join Pending Group Lawsuit A request filed in the state of New Jersey may lead to the creation of a group lawsuit for people who took Rybelsus and developed NAION (non-arteritic anterior ischemic optic neuropathy)

Ask yourself whether any of these apply so you can discuss personal risk with your clinician

The potential risks to the developing fetus are a significant concern

Itll typically be administered by a licensed professional in Dallas starting with a lower dose and gradually increased to minimize the potential risks of side effects

After the injection, you can eat and drink as usual

ORLANDO Semaglutide reduces risk for cardiovascular events among adults with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or change in HbA1c, according to data from the SELECT trial